retatrutide parkinson's disease trial nct A Double-Blind, Delayed-Start of Rasagiline in The NADPARK study: A randomized

This finding does not establish causality, but it is consistent with a model in which robust mitochondrial peptide signaling is a feature of successful aging rather than a peripheral correlate

Canary 21 Press

GLP-1 therapy is often recommended for those who: Have difficulty losing weight despite diet and exercise Experience issues with blood sugar control, such as prediabetes or Type 2 diabetes Want to manage appetite and improve energy levels At our Midtown Toronto clinic, your provider will assess your health goals and medical history to determine if GLP-1 therapy is right for you

However, without robust appetite modulation, the long-term effect on body composition may be limited